Outcomes in orthotopic heart transplantation following pacemaker implantation
Pacing and Clinical Electrophysiology · 2023
DOI: 10.1111/pace.14716 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pacing and Clinical Electrophysiology, 2023. Verfasst von Duc H Do und 7 weiteren Autor:innen. Beteiligte Einrichtung: UCLA Cardiac Arrhythmia Center, UCLA Health System, David Geffen School of Medicine at UCLA, Los Angeles, California, USA. Hauptthemen laut MEDLINE: Pacemaker, Artificial, Heart Transplantation, Atrioventricular Block, Atrial Fibrillation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Background
Bradyarrhythmias including sinus node dysfunction (SND) and atrioventricular block (AVB) can necessitate pacemaker (PPM) implantation in orthotopic heart transplant (OHT) recipients. Prior studies have shown conflicting findings regarding the effect of PPM implantation on survival. We evaluated the effect of PPM indication on long‐term re‐transplant‐free survival in OHT patients.
Methods
We conducted a retrospective cohort study of OHT patients at UCLA Medical Center from 1985 to 2018. Indication for PPM (SND, AVB) was identified. Cox proportional hazards model with pacemaker implantation as a time‐varying covariate was used to evaluate its effect on the primary endpoint of retransplant or death. We included 1609 OHTs in 1511 adult patients with median follow‐up of 12 years.
Results
At transplant, patients were aged 53 ± 13 years and 1125 (74.5%) were male. Pacemakers were implanted in 109 (7.2%) patients; 65 for SND (4.3%) and 43 for AVB (2.8%). Repeat OHT was performed in 103 (6.4%) cases and 798 (52.8%) patients died during the follow‐up period. The risk of the primary endpoint was significantly higher in patients requiring PPM for AVB (HR 3.0, 95% CI 2.1–4.2, p < .01) after controlling for age at OHT, gender, hypertension, diabetes, renal disease, history of repeat OHT, acute rejection, transplant coronary vasculopathy, and atrial fibrillation, but not PPM for SND (HR 1.0, 95% CI 0.70–1.4, p = 1.0).
Conclusions
Patients who required PPM for AVB, but not SND, were at significantly higher risk of death or retransplant compared to patients who did not require PPM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- UCLA Cardiac Arrhythmia Center, UCLA Health System, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
- UCLA Heart Transplant Program, UCLA Health System, David Geffen School of Medicine at UCLA, Los Angeles, California, USA.
ORCID-Profile: Duc H Do, Jason Bradfield, Noel G Boyle
Förderung
- NIH HHS
- National Institutes of Health
Zitieren
APA
Do, D. H., Bailey, K. L., Beyer, R., Neubuerger, S., Bradfield, J., Shivkumar, K., Nsair, A., & Boyle, N. G. (2023). Outcomes in orthotopic heart transplantation following pacemaker implantation. Pacing and Clinical Electrophysiology. https://doi.org/10.1111/pace.14716
Vancouver
Do DH, Bailey KL, Beyer R, Neubuerger S, Bradfield J, Shivkumar K, et al. Outcomes in orthotopic heart transplantation following pacemaker implantation. Pacing and Clinical Electrophysiology. 2023. doi:10.1111/pace.14716
BibTeX
@article{Do2023,
author = {Do, Duc H and Bailey, Katherine L and Beyer, Ryan and Neubuerger, Samuel and Bradfield, Jason and Shivkumar, Kalyanam and Nsair, Ali and Boyle, Noel G},
title = {Outcomes in orthotopic heart transplantation following pacemaker implantation},
journal = {Pacing and Clinical Electrophysiology},
year = {2023},
doi = {10.1111/pace.14716}
}
EUVIMED